[Skip to Content]
[Skip to Content Landing]
Article
Sept 1961

Corticotropin in the Treatment of TuberculosisA Controlled Study

Author Affiliations

BROOKLYN

Pulmonary Disease Division, Department of Medicine, Downstate Medical Center, State University of New York, Brooklyn.; Formerly Assistant Professor of Medicine, Downstate Medical Center, State University of New York; now at the Tuberculosis Research Unit, Medical Research Council, London England (Dr. Angel).

Arch Intern Med. 1961;108(3):353-369. doi:10.1001/archinte.1961.03620090025004
Abstract

Historical Introduction  Throughout the field of medicine, the use of corticotropin and the corticosteroid hormones has been controversial. This has especially been true in tuberculosis. The history of the use of the hormones in this disease falls into three phases. During the first phase, the hormones were used without any antituberculous therapy. This resulted in spread of active disease and reactivation of quiescent disease in tuberculous patients and the appearance of fresh disease in nontuberculous patients. This phase ended with the publication of the report of the Committee on Therapy of the American Trudeau Society (1952), which virtually placed an interdiction on the use of these hormones in tuberculosis. During the second phase, they were little used, especially in the United States. In Europe, some critically ill patients were treated with a combination of steroid hormones and antituberculous chemotherapy. Later, large numbers of patients treated with this combination were reported

First Page Preview View Large
First page PDF preview
First page PDF preview
×